4.3 Review

A Clear and Present Danger: Endogenous Ligands of Toll-like Receptors

Journal

NEUROMOLECULAR MEDICINE
Volume 12, Issue 2, Pages 149-163

Publisher

HUMANA PRESS INC
DOI: 10.1007/s12017-009-8094-x

Keywords

Toll-like receptors; Innate immunity; Heat shock proteins; Hyaluronan; HMGB1; Heparin sulfate; Necrosis

Categories

Funding

  1. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038475] Funding Source: NIH RePORTER
  2. NINDS NIH HHS [P01 NS038475-10, P01 NS038475] Funding Source: Medline

Ask authors/readers for more resources

Neurologic disease promoted by microbial pathogens, sterile injury, or neurodegeneration rapidly induces innate immunity in adjacent healthy tissue, which in turn contributes extensively to neurologic injury. With more recent focus on innate immune processes, it appears that necrotic, but not apoptotic, death mechanisms provoke inflammatory responses likely due to the release or production of endogenous ligands that activate resident immune cells of the central nervous system. These ligands comprise a diverse set of proteins, nucleic acids, and glycosaminoglycans, including heat shock proteins, HMGB1, RNA, DNA, hyaluronan, and heparin sulfate, that stimulate innate immune mechanisms largely through Toll-like receptors (TLRs). The blockade of interactions between endogenous ligands and TLRs may enable neuroprotective therapeutic strategies for a variety of neurologic diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available